312
Views
136
CrossRef citations to date
0
Altmetric
Review

Growth factor delivery for oral and periodontal tissue engineering

, &
Pages 647-662 | Published online: 01 Sep 2006

Bibliography

  • COCHRAN D: Implant therapy I. Ann. Periodontol. (1996) 1(1):707-791.
  • MARCUS PA, JOSHI A, JONES JA, MORGANO SM: Complete edentulism and denture use for elders in New England. J. Prosthet. Dent. (1996) 76(3):260-266.
  • DOUGLASS CW, SHIH A, OSTRY L: Will there be a need for complete dentures in the United States in 2020? J. Prosthet. Dent. (2002) 87(1):5-8.
  • NATIONAL CENTER FOR HEALTH STATISTICS: National Health Interview Survey (1998).
  • ALBANDAR JM, BRUNELLE JA, KINGMAN A: Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J. Periodontol. (1999) 70(1):13-29.
  • BELTRÁN-AGUILAR E, BARKER L, CANTO M et al.: Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis – United States, 1988-1994 and 1999-2002. MMWR (2005) 54(3):1-44.
  • TANG CS, NAYLOR AE: Single-unit implants versus conventional treatments for compromised teeth: a brief review of the evidence. J. Dent. Educ. (2005) 69(4):414-418.
  • MISCH CE: Dental Implant Prosthetics. Elsevier Mosby, St. Louis, MO, USA (2005).
  • CENTER FOR DISEASE CONTROL AND PREVENTION: Economic costs of birth defects and cerebral palsy – United States, 1992. MMWR (1995) 44(37):694-699.
  • LANGER R, VACANTI JP: Tissue engineering. Science (1993) 260(5110):920-926.
  • LE AD, BASI DL, ABUBAKER AO: Wound healing: findings of the 2005 AAOMS Research Summit. J. Oral Maxillofac. Surg. (2005) 63(10):1426-1435.
  • GIANNOBILE WV: Periodontal tissue engineering by growth factors. Bone (1996) 19(1 Suppl.):23S-37S.
  • ANUSAKSATHIEN O, GIANNOBILE WV: Growth factor delivery to re-engineer periodontal tissues. Curr. Pharm. Biotechnol. (2002) 3(2):129-139.
  • RIPAMONTI U, HERBST NN, RAMOSHEBI LN: Bone morphogenetic proteins in craniofacial and periodontal tissue engineering: experimental studies in the non-human primate Papio ursinus. Cytokine Growth Factor Rev. (2005) 16(3):357-368.
  • SCHILEPHAKE H: Bone growth factors in maxillofacial skeletal reconstruction. Int. J. Oral Maxillofac. Surg. (2002) 31(5):469-484.
  • BLAIR HC, ZAIDI M, SCHLESINGER PH: Mechanisms balancing skeletal matrix synthesis and degradation. Biochem. J. (2002) 364(Pt 2):329-341.
  • BLUMENTHAL NM, KOH-KUNST G, ALVES ME et al.: Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J. Periodontol. (2002) 73(12):1494-1506.
  • CHENG H, JIANG W, PHILLIPS FM et al.: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J. Bone Joint Surg. Am. (2003) 85-A(8):1544-1552.
  • WU XB, LI Y, SCHNEIDER A et al.: Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. (2003) 112(6):924-934.
  • MIKIC B, VAN DER MEULEN MC, KINGSLEY DM, CARTER DR: Long bone geometry and strength in adult BMP-5 deficient mice. Bone (1995) 16(4):445-454.
  • DUDLEY AT, LYONS KM, ROBERTSON EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. (1995) 9(22):2795-2807.
  • WINNIER G, BLESSING M, LABOSKY PA, HOGAN BL: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. (1995) 9(17):2105-2116.
  • ZHANG H, BRADLEY A: Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development (1996) 122(10):2977-2986.
  • SYKARAS N, OPPERMAN LA: Bone morphogenetic proteins (BMPs): how do they function and what can they offer the clinician? J. Oral Sci. (2003) 45(2):57-73.
  • BAYLINK DJ, FINKELMAN RD, MOHAN S: Growth factors to stimulate bone formation. J. Bone Miner. Res. (1993) 8(Suppl. 2):S565-S572.
  • JANSSENS K, TEN DIJKE P, JANSSENS S, VAN HUL W: Transforming growth factor-beta1 to the bone. Endocr. Rev. (2005) 26(6):743-774.
  • LINKHART TA, MOHAN S, BAYLINK DJ: Growth factors for bone growth and repair: IGF, TGF-β and BMP. Bone (1996) 19(Suppl. 1):1S-12S.
  • KING GN, COCHRAN DL: Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: a critical review. J. Periodontol. (2002) 73(8):925-936.
  • NYMAN S, GOTTLOW J, KARRING T, LINDHE J: The regenerative potential of the periodontal ligament. An experimental study in the monkey. J. Clin. Periodontol. (1982) 9(3):257-265.
  • GOTTLOW J, NYMAN S, KARRING T: Maintenance of new attachment gained through guided tissue regeneration. J. Clin. Periodontol. (1992) 19(5):315-317.
  • NYMAN S, LINDHE J, KARRING T, RYLANDER H: New attachment following surgical treatment of human periodontal disease. J. Clin. Periodontol. (1982) 9(4):290-296.
  • SCHENK RK, BUSER D, HARDWICK WR, DAHLIN C: Healing pattern of bone regeneration in membrane-protected defects: a histologic study in the canine mandible. Int. J. Oral Maxillofac. Implants (1994) 9(1):13-29.
  • LANG NP, WETZEL AC, STICH H, CAFFESSE RG: Histologic probe penetration in healthy and inflamed peri-implant tissues. Clin. Oral Implants Res. (1994) 5(4):191-201.
  • OH TJ, MERAW SJ, LEE EJ, GIANNOBILE WV, WANG HL: Comparative analysis of collagen membranes for the treatment of implant dehiscence defects. Clin. Oral Implants Res. (2003) 14(1):80-90.
  • GOTTLOW J: Guided tissue regeneration using bioresorbable and non-resorbable devices: initial healing and long-term results. J. Periodontol. (1993) 64(Suppl. 11):1157-1165.
  • ZITZMANN NU, NAEF R, SCHARER P: Resorbable versus nonresorbable membranes in combination with Bio-Oss for guided bone regeneration. Int. J. Oral Maxillofac. Implants (1997) 12(6):844-852.
  • CIRELLI JA, MARCANTONIO E Jr, ADRIANA R et al.: Evaluation of anionic collagen membranes in the treatment of class II furcation lesions: an histometric analysis in dogs. Biomaterials (1997) 18(18):1227-1234.
  • PITARU S, TAL H, SOLDINGER M, NOFF M: Collagen membranes prevent apical migration of epithelium and support new connective tissue attachment during periodontal wound healing in dogs. J. Periodontal Res. (1989) 24(4):247-253.
  • KIM BS, MOONEY DJ: Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. (1998) 16(5):224-230.
  • HARRIS LD, KIM BS, MOONEY DJ: Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. (1998) 42(3):396-402.
  • BUNYARATAVEJ P, WANG HL: Collagen membranes: a review. J. Periodontol. (2001) 72(2):215-229.
  • ALSBERG E, KONG HJ, HIRANO Y et al.: Regulating bone formation via controlled scaffold degradation. J. Dent. Res. (2003) 82(11):903-908.
  • KONG HJ, KAIGLER D, KIM K, MOONEY DJ: Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules (2004) 5(5):1720-1727.
  • HUANG YC, KAIGLER D, RICE KG, KREBSBACH PH, MOONEY DJ: Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. (2005) 20(5):848-857.
  • KAIGLER D, KREBSBACH PH, WEST ER et al.: Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J. (2005) 19(6):665-667.
  • ZHAO M, JIN Q, BERRY JE et al.: Cementoblast delivery for periodontal tissue engineering. J. Periodontol. (2004) 75(1):154-161.
  • IZUMI K, SONG J, FEINBERG SE: Development of a tissue-engineered human oral mucosa: from the bench to the bed side. Cells Tissues Organs (2004) 176(1-3):134-152.
  • PARENTEAU N: Skin: the first tissue-engineered products. Sci. Am. (1999) 280(4):83-84.
  • YOUNG CS, ABUKAWA H, ASRICAN R et al.: Tissue-engineered hybrid tooth and bone. Tissue Eng. (2005) 11(9-10):1599-1610.
  • ANUSAKSATHIEN O, WEBB SA, JIN QM, GIANNOBILE WV: Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng. (2003) 9(4):745-756.
  • POSTLETHWAITE AE, SEYER JM, KANG AH: Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. USA (1978) 75(2):871-875.
  • FREED LE, VUNJAK-NOVAKOVIC G, BIRON RJ et al.: Biodegradable polymer scaffolds for tissue engineering. Biotechnology (NY) (1994) 12(7):689-693.
  • BELL E, IVARSSON B, MERRILL C: Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA (1979) 76(3):1274-1278.
  • VAN HEST JC, TIRRELL DA: Protein-based materials, toward a new level of structural control. Chem. Commun. (Camb.) (2001) 19:1897-1904.
  • MURPHY WL, SIMMONS CA, KAIGLER D, MOONEY DJ: Bone regeneration via a mineral substrate and induced angiogenesis. J. Dent Res. (2004) 83(3):204-210.
  • CHANG SC, ROWLEY JA, TOBIAS G et al.: Injection molding of chondrocyte/alginate constructs in the shape of facial implants. J. Biomed. Mater. Res. (2001) 55(4):503-511.
  • HALBERSTADT C, AUSTIN C, ROWLEY J et al.: A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tissue Eng. (2002) 8(2):309-319.
  • ALSBERG E, HILL EE, MOONEY DJ: Craniofacial tissue engineering. Crit. Rev. Oral Biol. Med. (2001) 12(1):64-75.
  • SHAKESHEFF K, CANNIZZARO S, LANGER R: Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. J. Biomater. Sci. Polym. Ed. (1998) 9(5):507-518.
  • ROWLEY JA, MADLAMBAYAN G, MOONEY DJ: Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials (1999) 20(1):45-53.
  • LENDLEIN A, LANGER R: Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science (2002) 296(5573):1673-1676.
  • THORNTON AJ, ALSBERG E, ALBERTELLI M, MOONEY DJ: Shape-defining scaffolds for minimally invasive tissue engineering. Transplantation (2004) 77(12):1798-1803.
  • STAYTON PS, EL-SAYED ME, MURTHY N et al.: 'Smart' delivery systems for biomolecular therapeutics. Orthod. Craniofac. Res. (2005) 8(3):219-225.
  • AGULNIK M, SIU LL: An update on the systemic therapy of malignant salivary gland cancers: role of chemotherapy and molecular targeted agents. Curr. Med. Chem. Anticancer Agents (2004) 4(6):543-551.
  • TZIAFAS D: The future role of a molecular approach to pulp-dentinal regeneration. Caries Res. (2004) 38(3):314-320.
  • SMITH AJ: Vitality of the dentin-pulp complex in health and disease: growth factors as key mediators. J. Dent. Educ. (2003) 67(6):678-689.
  • NAKASHIMA M, TACHIBANA K, IOHARA K et al.: Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum. Gene Ther. (2003) 14(6):591-597.
  • NISHIMURA F, TERRANOVA VP: Comparative study of the chemotactic responses of periodontal ligament cells and gingival fibroblasts to polypeptide growth factors. J. Dent. Res. (1996) 75(4):986-992.
  • SAYGIN NE, TOKIYASU Y, GIANNOBILE WV, SOMERMAN MJ: Growth factors regulate expression of mineral associated genes in cementoblasts. J. Periodontol. (2000) 71(10):1591-1600.
  • STRAYHORN CL, GARRETT JS, DUNN RL, BENEDICT JJ, SOMERMAN MJ: Growth factors regulate expression of osteoblast-associated genes. J. Periodontol. (1999) 70(11):1345-1354.
  • CANALIS E: Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. Metabolism (1981) 30(10):970-975.
  • BARTOLD PM, RABEN A: Growth factor modulation of fibroblasts in simulated wound healing. J. Periodontal Res. (1996) 31(3):205-216.
  • OJIMA Y, MIZUNO M, KUBOKI Y, KOMORI T: In vitro effect of platelet-derived growth factor-BB on collagen synthesis and proliferation of human periodontal ligament cells. Oral Dis. (2003) 9(3):144-151.
  • REIGSTAD LJ, VARHAUG JE, LILLEHAUG JR: Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. (2005) 272(22):5723-5741.
  • BOYAN LA, BHARGAVA G, NISHIMURA F et al.: Mitogenic and chemotactic responses of human periodontal ligament cells to the different isoforms of platelet-derived growth factor. J. Dent. Res. (1994) 73(10):1593-1600.
  • MATSUDA N, LIN WL, KUMAR NM, CHO MI, GENCO RJ: Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J. Periodontol. (1992) 63(6):515-525.
  • LYNCH SE, BUSER D, HERNANDEZ RA et al.: Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs. J. Periodontol. (1991) 62(11):710-716.
  • LYNCH SE, DE CASTILLA GR, WILLIAMS RC et al.: The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J. Periodontol. (1991) 62(7):458-467.
  • LYNCH SE, WILLIAMS RC, POLSON AM et al.: A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J. Clin. Periodontol. (1989) 16(8):545-548.
  • GIANNOBILE WV, FINKELMAN RD, LYNCH SE: Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J. Periodontol. (1994) 65(12):1158-1168.
  • GIANNOBILE WV, HERNANDEZ RA, FINKELMAN RD et al.: Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J. Periodontal Res. (1996) 31(5):301-312.
  • STEFANI CM, MACHADO MA, SALLUM EA et al.: Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs. Implant. Dent. (2000) 9(2):126-131.
  • HOWELL TH, FIORELLINI JP, PAQUETTE DW et al.: A Phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J. Periodontol. (1997) 68(12):1186-1193.
  • PARK JB, MATSUURA M, HAN KY et al.: Periodontal regeneration in class III furcation defects of beagle dogs using guided tissue regenerative therapy with platelet-derived growth factor. J. Periodontol. (1995) 66(6):462-477.
  • CHO MI, LIN WL, GENCO RJ: Platelet-derived growth factor-modulated guided tissue regenerative therapy. J. Periodontol. (1995) 66(6):522-530.
  • WANG HL, PAPPERT TD, CASTELLI WA et al.: The effect of platelet-derived growth factor on the cellular response of the periodontium: an autoradiographic study on dogs. J. Periodontol. (1994) 65(5):429-436.
  • CAMELO M, NEVINS ML, SCHENK RK, LYNCH SE, NEVINS M: Periodontal regeneration in human class II furcations using purified recombinant human platelet-derived growth factor-BB (rhPDGF-BB) with bone allograft. Int. J. Periodontics Restorative Dent. (2003) 23(3):213-225.
  • NEVINS M, CAMELO M, NEVINS ML, SCHENK RK, LYNCH SE: Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J. Periodontol. (2003) 74(9):1282-1292.
  • NEVINS M, GIANNOBILE WV, MCGUIRE MK et al.: Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J. Periodontol. (2005) 76(12):2205-2215.
  • TAKAYAMA S, MURAKAMI S, MIKI Y et al.: Effects of basic fibroblast growth factor on human periodontal ligament cells. J. Periodontal Res. (1997) 32(8):667-675.
  • TERRANOVA VP, ODZIEMIEC C, TWEDEN KS, SPADONE DP: Repopulation of dentin surfaces by periodontal ligament cells and endothelial cells. Effect of basic fibroblast growth factor. J. Periodontol. (1989) 60(6):293-301.
  • ROSSA C, JR., MARCANTONIO E Jr, CIRELLI JA et al.: Regeneration of class III furcation defects with basic fibroblast growth factor (b-FGF) associated with GTR. A descriptive and histometric study in dogs. J. Periodontol. (2000) 71(5):775-784.
  • MURAKAMI S, TAKAYAMA S, KITAMURA M et al.: Recombinant human basic fibroblast growth factor (bFGF) stimulates periodontal regeneration in class II furcation defects created in beagle dogs. J. Periodontal Res. (2003) 38(1):97-103.
  • NAKAHARA T, NAKAMURA T, KOBAYASHI E et al.: Novel approach to regeneration of periodontal tissues based on in situ tissue engineering: effects of controlled release of basic fibroblast growth factor from a sandwich membrane. Tissue Eng. (2003) 9(1):153-162.
  • SATO Y, KIKUCHI M, OHATA N, TAMURA M, KUBOKI Y: Enhanced cementum formation in experimentally induced cementum defects of the root surface with the application of recombinant basic fibroblast growth factor in collagen gel in vivo. J. Periodontol. (2004) 75(2):243-248.
  • TAKAYAMA S, MURAKAMI S, SHIMABUKURO Y, KITAMURA M, OKADA H: Periodontal regeneration by FGF-2 (bFGF) in primate models. J. Dent. Res. (2001) 80(12):2075-2079.
  • CLOKIE CM, BELL RC: Recombinant human transforming growth factor β-1 and its effects on osseointegration. J. Craniofac. Surg. (2003) 14(3):268-277.
  • TATAKIS DN, WIKESJO UM, RAZI SS et al.: Periodontal repair in dogs: effect of transforming growth factor-β1 on alveolar bone and cementum regeneration. J. Clin. Periodontol. (2000) 27(9):698-704.
  • WIKESJO UM, RAZI SS, SIGURDSSON TJ et al.: Periodontal repair in dogs: effect of recombinant human transforming growth factor-β1 on guided tissue regeneration. J. Clin. Periodontol. (1998) 25(6):475-481.
  • MOHAMMED S, PACK AR, KARDOS TB: The effect of transforming growth factor-β1 (TGF-β1) on wound healing, with or without barrier membranes, in a class II furcation defect in sheep. J. Periodontal Res. (1998) 33(6):335-344.
  • SIGURDSSON TJ, LEE MB, KUBOTA K et al.: Periodontal repair in dogs: recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration. J. Periodontol. (1995) 66(2):131-138.
  • WIKESJO UM, XIROPAIDIS AV, THOMSON RC et al.: Periodontal repair in dogs: space-providing ePTFE devices increase rhBMP-2/ACS-induced bone formation. J. Clin. Periodontol. (2003) 30(8):715-725.
  • SORENSEN RG, WIKESJO UM, KINOSHITA A, WOZNEY JM: Periodontal repair in dogs: evaluation of a bioresorbable calcium phosphate cement (Ceredex) as a carrier for rhBMP-2. J. Clin. Periodontol. (2004) 31(9):796-804.
  • CHOI SH, KIM CK, CHO KS et al.: Effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) on healing in 3-wall intrabony defects in dogs. J. Periodontol. (2002) 73(1):63-72.
  • KING GN, KING N, CRUCHLEY AT, WOZNEY JM, HUGHES FJ: Recombinant human bone morphogenetic protein-2 promotes wound healing in rat periodontal fenestration defects. J. Dent. Res. (1997) 76(8):1460-1470.
  • HIGUCHI T, KINOSHITA A, TAKAHASHI K, ODA S, ISHIKAWA I: Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling. J. Periodontol. (1999) 70(9):1026-1031.
  • WIKESJO UM, XIROPAIDIS AV, THOMSON RC et al.: Periodontal repair in dogs: rhBMP-2 significantly enhances bone formation under provisions for guided tissue regeneration. J. Clin. Periodontol. (2003) 30(8):705-714.
  • WIKESJO UM, LIM WH, THOMSON RC et al.: Periodontal repair in dogs: evaluation of a bioabsorbable space-providing macroporous membrane with recombinant human bone morphogenetic protein-2. J. Periodontol. (2003) 74(5):635-647.
  • WIKESJO UM, GUGLIELMONI P, PROMSUDTHI A et al.: Periodontal repair in dogs: effect of rhBMP-2 concentration on regeneration of alveolar bone and periodontal attachment. J. Clin. Periodontol. (1999) 26(6):392-400.
  • TAKAHASHI D, ODAJIMA T, MORITA M, KAWANAMI M, KATO H: Formation and resolution of ankylosis under application of recombinant human bone morphogenetic protein-2 (rhBMP-2) to class III furcation defects in cats. J. Periodontal Res. (2005) 40(4):299-305.
  • WIKESJO UM, QAHASH M, THOMSON RC et al.: rhBMP-2 significantly enhances guided bone regeneration. Clin. Oral Implants Res. (2004) 15(2):194-204.
  • HANISCH O, SORENSEN RG, KINOSHITA A et al.: Effect of recombinant human bone morphogenetic protein-2 in dehiscence defects with non-submerged immediate implants: an experimental study in Cynomolgus monkeys. J. Periodontol. (2003) 74(5):648-657.
  • HANISCH O, TATAKIS DN, BOSKOVIC MM, ROHRER MD, WIKESJO UM: Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int. J. Oral Maxillofac. Implants (1997) 12(5):604-610.
  • HANISCH O, TATAKIS DN, ROHRER MD et al.: Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int. J. Oral Maxillofac. Implants (1997) 12(6):785-792.
  • WIKESJO UM, SORENSEN RG, WOZNEY JM: Augmentation of alveolar bone and dental implant osseointegration: clinical implications of studies with rhBMP-2. J. Bone Joint Surg. Am. (2001) 83-A(Suppl. 1, Pt 2):S136-S145.
  • BARBOZA EP, CAULA AL, CAULA FDE O et al.: Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J. Periodontol. (2004) 75(5):702-708.
  • BOYNE PJ, MARX RE, NEVINS M et al.: A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int. J. Periodontics Restorative Dent. (1997) 17(1):11-25.
  • JUNG RE, GLAUSER R, SCHARER P et al.: Effect of rhBMP-2 on guided bone regeneration in humans. Clin. Oral Implants Res. (2003) 14(5):556-568.
  • HOWELL TH, FIORELLINI J, JONES A et al.: A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int. J. Periodontics Restorative Dent. (1997) 17(2):124-139.
  • BOYNE PJ, LILLY LC, MARX RE et al.: De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J. Oral Maxillofac. Surg. (2005) 63(12):1693-1707.
  • GIANNOBILE WV, RYAN S, SHIH MS et al.: Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J. Periodontol. (1998) 69(2):129-137.
  • RIPAMONTI U, CROOKS J, PETIT JC, RUEGER DC: Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). Eur. J. Oral Sci. (2001) 109(4):241-248.
  • RIPAMONTI U, HELIOTIS M, RUEGER DC, SAMPATH TK: Induction of cementogenesis by recombinant human osteogenic protein-1 (hop-1/bmp-7) in the baboon (Papio ursinus). Arch. Oral Biol. (1996) 41(1):121-126.
  • COOK SD, SALKELD SL, RUEGER DC: Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites. J. Oral Implantol. (1995) 21(4):281-289.
  • ZHANG R, AN Y, TOTH CA et al.: Osteogenic protein-1 enhances osseointegration of titanium implants coated with peri-apatite in rabbit femoral defect. J. Biomed Mater. Res. B Appl. Biomater. (2004) 71(2):408-413.
  • MARGOLIN MD, COGAN AG, TAYLOR M et al.: Maxillary sinus augmentation in the non-human primate: a comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J. Periodontol. (1998) 69(8):911-919.
  • VAN DEN BERGH JP, TEN BRUGGENKATE CM, GROENEVELD HH, BURGER EH, TUINZING DB: Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J. Clin. Periodontol. (2000) 27(9):627-636.
  • WOLFMAN NM, HATTERSLEY G, COX K et al.: Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-β gene family. J. Clin. Invest. (1997) 100(2):321-330.
  • WIKESJO UM, SORENSEN RG, KINOSHITA A, JIAN LI X, WOZNEY JM: Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J. Clin. Periodontol. (2004) 31(8):662-670.
  • HAMMARSTROM L: Enamel matrix, cementum development and regeneration. J. Clin. Periodontol. (1997) 24(9 Pt 2):658-668.
  • HAMMARSTROM L, HEIJL L, GESTRELIUS S: Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J. Clin. Periodontol. (1997) 24(9 Pt 2):669-677.
  • GIANNOBILE WV, AL-SHAMMARI KF, SARMENT DP: Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol. 2000 (2003) 31:125-134.
  • VENEZIA E, GOLDSTEIN M, BOYAN BD, SCHWARTZ Z: The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis. Crit. Rev. Oral Biol. Med. (2004) 15(6):382-402.
  • ESPOSITO M, GRUSOVIN MG, COULTHARD P, WORTHINGTON HV: Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. Cochrane Database Syst. Rev. (2005) 4:CD003875.
  • ANUSAKSATHIEN O, JIN Q, MA PX, GIANNOBILE WV: Scaffolding in periodontal engineering. In: Scaffolding in Tissue Engineering. PX Ma, J Elisseeff (Eds), CRC Press, Boca Raton, FL, USA (2006):437-454.
  • MURPHY WL, PETERS MC, KOHN DH, MOONEY DJ: Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials (2000) 21(24):2521-2527.
  • WEI G, JIN Q, GIANNOBILE WV, MA PX: Nanofibrous scaffold for controlled delivery of recombinant human PDGF-BB. J. Control. Release (2006) 112(1):103-110.
  • CHANG SC, WEI FC, CHUANG H et al.: Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast. Reconstr. Surg. (2003) 112(7):1841-1850.
  • BAUM BJ, O'CONNELL BC: In vivo gene transfer to salivary glands. Crit. Rev. Oral Biol. Med. (1999) 10(3):276-283.
  • DELPORTE C, O'CONNELL BC, HE X et al.: Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc. Natl. Acad. Sci. USA (1997) 94(7):3268-3273.
  • HENDRIE PC, RUSSELL DW: Gene targeting with viral vectors. Mol. Ther. (2005) 12(1):9-17.
  • RAMSEIER CA, ABRAMSON Z, JIN Q, GIANNOBILE W: Gene therapy for periodontal regenerative medicine. Dent. Clin. N. Amer. (2006) 50(2):245-263.
  • WORGALL S: A realistic chance for gene therapy in the near future. Pediatr. Nephrol. (2005) 20(2):118-124.
  • ZHU Z, LEE CS, TEJEDA KM, GIANNOBILE WV: Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J. Dent. Res. (2001) 80(3):892-897.
  • THOMAS CE, EHRHARDT A, KAY MA: Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. (2003) 4(5):346-358.
  • GARDLIK R, PALFFY R, HODOSY J et al.: Vectors and delivery systems in gene therapy. Med. Sci. Monit. (2005) 11(4):RA110-RA121.
  • SCHMIDT-WOLF GD, SCHMIDT-WOLF IG: Non-viral and hybrid vectors in human gene therapy: an update. Trends Mol. Med. (2003) 9(2):67-72.
  • LATTANZI W, POLA E, PECORINI G, LOGROSCINO CA, ROBBINS PD: Gene therapy for in vivo bone formation: recent advances. Eur. Rev. Med. Pharmacol. Sci. (2005) 9(3):167-174.
  • GIANNOBILE WV, LEE CS, TOMALA MP, TEJEDA KM, ZHU Z: Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J. Periodontol. (2001) 72(6):815-823.
  • CHEN QP, GIANNOBILE WV: Adenoviral gene transfer of PDGF downregulates gas gene product PDGFαR and prolongs ERK and Akt/PKB activation. Am. J. Physiol. Cell Physiol. (2002) 282(3):C538-C544.
  • JIN QM, ANUSAKSATHIEN O, WEBB SA, RUTHERFORD RB, GIANNOBILE WV: Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J. Periodontol. (2003) 74(2):202-213.
  • JIN Q, ANUSAKSATHIEN O, WEBB SA, PRINTZ MA, GIANNOBILE WV: Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol. Ther. (2004) 9(4):519-526.
  • DUNN CA, JIN Q, TABA M Jr et al.: BMP gene delivery for alveolar bone engineering at dental implant defects. Mol. Ther. (2005) 11(2):294-299.
  • GAILIT J, CLARK RA: Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. (1994) 6(5):717-725.
  • SINGER AJ, CLARK RA: Cutaneous wound healing. N. Engl. J. Med. (1999) 341(10):738-746.
  • CLARK RA: Wound repair. Curr. Opin. Cell Biol. (1989) 1(5):1000-1008.
  • SELVIG KA, SORENSEN RG, WOZNEY JM, WIKESJO UM: Bone repair following recombinant human bone morphogenetic protein-2 stimulated periodontal regeneration. J. Periodontol. (2002) 73(9):1020-1029.
  • SIGURDSSON TJ, NYGAARD L, TATAKIS DN et al.: Periodontal repair in dogs: evaluation of rhBMP-2 carriers. Int. J. Periodontics Restorative Dent. (1996) 16(6):524-537.
  • KINOSHITA A, ODA S, TAKAHASHI K, YOKOTA S, ISHIKAWA I: Periodontal regeneration by application of recombinant human bone morphogenetic protein-2 to horizontal circumferential defects created by experimental periodontitis in beagle dogs. J. Periodontol. (1997) 68(2):103-109.
  • ZELLIN G, LINDE A: Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects. J. Biomed. Mater. Res. (1997) 35(2):181-190.
  • NEVINS M, KIRKER-HEAD C, WOZNEY JA, PALMER R, GRAHAM D: Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2. Int. J. Periodontics Restorative Dent. (1996) 16(1):8-19.
  • LINDSEY WH: Osseous tissue engineering with gene therapy for facial bone reconstruction. Laryngoscope (2001) 111(7):1128-1136.
  • ALDEN TD, BERES EJ, LAURENT JS et al.: The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J. Craniofac. Surg. (2000) 11(1):24-30.
  • MACK CA, MAGOVERN CJ, BUDENBENDER KT et al.: Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J. Vasc. Surg. (1998) 27(4):699-709.
  • KREBSBACH PH, GU K, FRANCESCHI RT, RUTHERFORD RB: Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. (2000) 11(8):1201-1210.
  • PENG H, WRIGHT V, USAS A et al.: Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Invest. (2002) 110(6):751-759.
  • ZHENG C, HOQUE AT, BRADDON VR, BAUM BJ, O'CONNELL BC: Evaluation of salivary gland acinar and ductal cell-specific promoters in vivo with recombinant adenoviral vectors. Hum. Gene Ther. (2001) 12(18):2215-2223.
  • YAMANO S, ATKINSON JC, BAUM BJ, FOX PC: Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin. Immunol. (1999) 92(3):265-275.
  • YAMANO S, SCOTT DE, HUANG LY et al.: Protection from experimental endotoxemia by a recombinant adeno-associated virus encoding interleukin 10. J. Gene Med. (2001) 3(5):450-457.
  • VITOLO JM, BAUM BJ: The use of gene transfer for the protection and repair of salivary glands. Oral Dis. (2002) 8(4):183-191.
  • NAKASHIMA M, IOHARA K, ISHIKAWA M et al.: Stimulation of reparative dentin formation by ex vivo gene therapy using dental pulp stem cells electrotransfected with growth/differentiation factor 11 (Gdf11). Hum. Gene Ther. (2004) 15(11):1045-1053.
  • NAKASHIMA M, MIZUNUMA K, MURAKAMI T, AKAMINE A: Induction of dental pulp stem cell differentiation into odontoblasts by electroporation-mediated gene delivery of growth/differentiation factor 11 (Gdf11). Gene Ther. (2002) 9(12):814-818.
  • RUTHERFORD RB: BMP-7 gene transfer to inflamed ferret dental pulps. Eur. J. Oral Sci. (2001) 109(6):422-424.
  • KUBOKI T, NAKANISHI T, KANYAMA M et al.: Direct adenovirus-mediated gene delivery to the temporomandibular joint in guinea-pigs. Arch. Oral Biol. (1999) 44(9):701-709.
  • ANUSAKSATHIEN O, JIN Q, ZHAO M, SOMERMAN MJ, GIANNOBILE WV: Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J. Periodontol. (2004) 75(3):429-440.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.